Rep. Burgess Condemns Biden Administration's Drug Price Controls
August 30, 2023
August 30, 2023
WASHINGTON, Aug. 30 -- Rep. Michael Burgess, R-Texas, issued the following statement on Aug. 29, 2023:
* * *
Congressman Michael C. Burgess, M.D. (R-TX), Vice Chairman of the House Rules Committee, released the following statement in response to the Biden Administration's announcement of the first ten drugs selected for Medicare price negotiation.
"The so-called 'Inflation Reduction Act' mandates the Centers for Medicare & Medicaid Services (CMS) t . . .
* * *
Congressman Michael C. Burgess, M.D. (R-TX), Vice Chairman of the House Rules Committee, released the following statement in response to the Biden Administration's announcement of the first ten drugs selected for Medicare price negotiation.
"The so-called 'Inflation Reduction Act' mandates the Centers for Medicare & Medicaid Services (CMS) t . . .